期刊
NATURE PROTOCOLS
卷 5, 期 4, 页码 811-820出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nprot.2010.16
关键词
-
资金
- MICINN
- CIBER
- Fondo de Investigaciones Sanitarias [RETIC-RD06/0010/0016]
- TERCEL
- G. Harold and Leila Y. Mathers Charitable Foundation
- Fundacion Cellex
Induced pluripotent stem cells (iPSC) provide an invaluable resource for regenerative medicine as they allow the generation of patient-specific progenitors with potential value for cell therapy. However, in many instances, an off-the-shelf approach is desirable, such as for cell therapy of acute conditions or when the patient's somatic cells are altered as a consequence of a chronic disease or aging. Cord blood (CB) stem cells appear ideally suited for this purpose as they are young cells expected to carry minimal somatic mutations and possess the immunological immaturity of newborn cells; additionally, several hundred thousand immunotyped CB units are readily available through a worldwide network of CB banks. Here we present a detailed protocol for the derivation of CB stem cells and how they can be reprogrammed to pluripotency by retroviral transduction with only two factors (OCT4 and SOX2) in 2 weeks and without the need for additional chemical compounds.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据